Dr. Patrick Loehrer
Excellence in Thymic Cancer Research at the Indiana University Cancer Center
Who is Patrick Loehrer ?
|The Indiana University Cancer Center has considerable expertise in the treatment of thymomas and thymic malignancies. Under the direction of Dr. Patrick J. Loehrer, Sr., M.D., more patients with advanced thymoma are treated at the Indiana University Cancer Center than any other cancer center in the world. While many oncologists will see a thymoma case once or twice in their career, Dr. Loehrer sees between 5-10 patients a month. In addition, Dr. Loehrer fields hundreds of calls and emails annually from physicians and patients worldwide to provide diagnosis, treatment, and consultation services. read more|
|What are his credentials ?||You will find everything here.|
|What is he doing now ?||look here.|
|How can he help me ?||As one of the worlds top thymoma researcher he told thymoma.de, that he would help every person (no matter where in the world) by giving his opinion about the most successful treatment to his knowledge.|
|What does his help cost ?||Would you belive, he works for free?
No, you would not think so.
But in fact he does phone and email support without charging the patients or the doctors, who call him from all over the world, a cent.
So how does it work? read more
|How can I reach him ?||
Patrick J. Loehrer Sr. M.D.
Letters from patients regarding Patrick Loehrer
I sent information on Sue's new web site to Dr. Loehrer. It looks like the
Indiana University Fund raising group responded with his bio information. Dr.
Loehrer is my doctor--thanks to a referral from Furball who had done the doctor
research first. Many of us using this site are patients. I would highly recommend
Dr. Loehrer and encourage any/all of you to be in contact with him about your
condition. He sees more thymoma patients than anyone else and this benefits
us all. He has the experience we needed to get the best treatment/care available.
I can say that my own treatment would have been entirely different and not in a good way had I followed the advice I received from a good local doctor--simply because he had not dealt with thymoma as many doctors have not. We all have to manage our own medical care and my own opinion is that I will go with Dr. Loehrer and what he recommends and never feel that I have any regrets about my treatment at any time. He also works with a great surgeon for those that might need surgery. I can't say enough good about Dr. Kesler--contact him via Dr. Loehrer.
I highly encourage any of you dealing with thymoma to call Dr. Loehrer or have your doctor call. You don't necessarily have to go to Indianapolis to take advantage of his expertise.
As for the fund raising, when I started being treated by Dr. Loehrer, we learned that one of the fund raising people there was the sister of a good friend of ours. She told us that no one had ever given any money to the Hospital for thymoma research--not even $1. Certainly there are people battling this disease that cannot give money to research due to medical bills. But if you can, or if others want to do something for you, this would be a great thing to do or suggest to others. My husband and I gave as much as his company would match on an annual basis last year. My co-workers, classmates, friends and family donated another $2,000+ so the fund is growing. I can tell you that Dr. Loehrer will squeeze as much out of every single dollar as humanly possible--so whatever amount you can give WILL make a difference.
I would be happy to answer anyone's emails with information about my treatment/care, my experience with Dr. Loehrer/IU Hospital or anything you want to talk about. You can email me at email@example.com
From: Sue & Joe
Reply To: Sue & Joe
Sent: Monday, April 2, 2001 8:50 PM
To: Loehrer, Patrick
Subject: thymoma.de again
just a short question
when we started finding things out about thymoma in 95 we found data, that
the survival rate for a 4a was around 25%
now, just as i updated the thymoma database i stumbled over a simmular
number ( see below)
do you have data what confirms these survival rate or what is your
(short answer is ok)
thank you for your time
A 25-year thymoma treatment review.
AU - Whooley BP; Urschel JD; Antkowiak JG; Takita H SO - J Exp Clin Cancer
Res 2000 Mar;19(1):3-5
AD - Dept. of Thoracic Surgical Oncology, Roswell Park Cancer Institute,
Buffalo, NY, USA.
Most thymomas are stage I or II at presentation, and they have a good
prognosis with surgical treatment. Higher stage thymomas are less common
and their treatment is more problematic. Our center tends to attract
patients with higher stage thymomas for treatment. We reviewed our
experience and contrasted it with other published series.
A 25-year retrospective record review of thymomas was done. 38 patients
were treated. Median age was 49 years. Four had myasthenia gravis. Masaoka
staging was: stage I--9; stage II--6; stage III--15; stage IVa--4; stage
IVb--4. Resection was done in 25 patients (21 had R0 resection),
chemotherapy was given to 15 patients, and 27 patients received
radiotherapy. Overall median survival was 55 months. Overall 5 and 10-year
survivals were 30% and 18%. 5-year survival by stage was: stage I--75%;
stage II--50%; stage III/IV--23%.
i think 3 4a and 4b in one group is kind of not right
Negative prognostic factors on univariate analysis included presence of
symptoms at presentation (p = 0.02), unresectable tumor (p = 0.06), stage
III/IV (p = 0.04), and disease recurrence after resection (p = 0.0001). On
multivariate analysis, only stage (p = 0.04) and recurrence (p = 0.0001)
were independent predictors of survival.
All patients who recurred after resection eventually died of disease.
(can you confirm this too?)
Our overall treatment results are disappointing, but we had higher stage
patients than reported by most other centers. Early stage thymomas are
suitable for complete surgical resection, and the prognosis is favorable.
However, higher stage thymomas (stage III and higher) pose problems for
complete surgical resection and their prognosis is poor. Newer
multimodality treatment approaches are indicated for higher stage
This is from a surgical perspective. The 5 year survival for Stage 4 with
PAC chemothereapy is about 33% and for Stage 3 about 50%
Sent: Sunday, April 29, 2001 9:09 PM
To: Loehrer, Patrick
Subject: Link between Melanoma+Thymoma???
today I received the following e-mail from a female thymoma patient and I
would like to know your opinion about it:
!!! I have a new oncologist who came to my hospital (Geisinger Medical
Center) from Memorial Sloan Ketterling in New York!! He is wonderful !!
He is very, very knowledgable of thymoma. He suggested I have a Mammogram
since I've never had one yet. He also referred me to a dermatologist to
have a few moles checked out. He says there is a link between melonoma
and thymoma. !!!!!
Pat, I have never heard about a link between melanoma +thymoma and so far
none of "my" patients ( 65 people)
had any problem with skin cancer.
Have a nice day and thanks for your help.
from thymoma.de ( right now in Germany)
About 1 in 5 patients with thymoma have a secondary malignancy. I haven't
seen melanoma but if the patient has dysplastic nevi, he or she should
follow up on it.
e-mail from 09.04.2001 from Vickie to Sue:
Sue, I have to tell you, I am so excited. On your recommendation, I called Dr. Loehrer today and he is going to see me September 17, 2001. I have called my surgeon and the hospital here and they are all rounding up the records, test results, etc. that I will need to take with me to Indiana. It is a 10 hour drive for me, but that is ok. My sister is going to go with me. I feel so good, because I feel like I am in control of who is going to treat me. Thank you so much for recommending him and I will keep in touch. Vickie Heyer --------